AMANDA MATHER: Open Payments
NPI 1134825169 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,185 in 56 payments from 22 companies in 2025. Trend: 2023 $1,007 · 2024 $1,708 · 2025 $1,185
Food & beverage: $1,185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $175 |
| Lilly USA, LLC | 10 | $161 |
| Gilead Sciences, Inc. | 2 | $128 |
| Exact Sciences Corporation | 1 | $98 |
| Merck Sharp & Dohme LLC | 1 | $98 |
| Phathom Pharmaceuticals, Inc. | 2 | $78 |
| Novo Nordisk Inc | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Eisai Inc. | 2 | $42 |
Products named: VRAYLAR, Epclusa, The Cologuard Plus Collection Kit, CAPVAXIVE, MOUNJARO, VOQUEZNA, JARDIANCE, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
